Doctors or midwives record three standard projections from the newborn’s echocardiogram (Echo) of the heart, obtaining results indicating the presence or absence of congenital heart defects (CHD). This system complements screenings that focus only on critical CHDs detected by the imperfect pulse oximeter.
The solution is being developed by leading medical and AI scientists.
Our solution involves making a system of diagnostic image analysis algorithms available in the cloud through a web browser. UES is not dedicated to specific manufacturers and does not require installation on a computer desktop or the device itself. The system operates simply and intuitively. It requires recording of standard defined projections and uploading them in the browser window. Preliminary surveys suggest that such recordings, without their specialized analysis, can be effectively made by medical staff with basic competencies in conducting ultrasound scans of newborns. All other actions are performed automatically by the system. Therefore, this solution can provide diagnostic support, utilizing the principles of the existing procedure without involving a specialist whose availability at this stage is deficient and impossible to obtain for every examined patient.
The current postnatal procedure involves conducting a pulseoximetry test on newborns in the delivery room as part of the general assessment of the newborn’s condition using the APGAR scale. Pulseoximeters, which are non-invasively placed on the newborns’ limbs, measure blood saturation and oxygenation levels. Despite significant advancements in medical technology, this diagnostic method still has limitations in effectiveness.
The idea behind UES is to provide the capability for comprehensive diagnostics supported by echocardiographic (ECHO) examinations, utilizing the available medical staff and enhanced by the UES system. This involves a more integrated approach to newborn heart health assessment, combining the initial pulseoximetry screening with the advanced capabilities of echocardiography, analyzed through UES algorithms.
This approach seeks to improve the detection and diagnosis of congenital heart defects in newborns, leveraging current medical practices and technology to provide a more reliable and comprehensive assessment right from the start. The goal is to enhance the standard newborn cardiac assessment procedures, ensuring that potential heart defects are identified and addressed as early as possible.
Founder and board member Prometheus Med Tech.AI Tomasz Bartosiak is a speaker on the AI for Health panel at the…
We had the privilege of attending the 2024 World Congress, hosted by the leading international organization dedicated to promoting education…
The organizer of the Symposium was Dr. Witold Błaż from the Provincial Hospital No. 2. Saint Jadwiga Queen in Rzeszów….
On Sunday (September 15), our project was discussed in the Dzień Dobry TVN program.A member of our team Professor Robert…
We invite you to watch the video presenting the InteliCardio project, titled “Artificial Intelligence (AI) in the Diagnosis of Congenital…
Wiktor Strzelczyk, Founder of Prometheus Medtech.AI, will be one of the experts in a panel dedicated to the development of…
The Serce Dziecka Foundation is launching the InteliCardio training and research project. This initiative combines the fields of medicine and…
Ultra Echo Scan (UES), which supports the diagnosis of Congenital Heart Defects in Fetuses using artificial intelligence (AI), has been…
This is a great honor for us! On Tuesday, June 4, as one of the 4 selected startups featured in…
During the event, Prof. M. Marcin Wiechec MD PhD, together with Agnieszka Nocuń MD, PhD, presented the groundbreaking importance of…
Yesterday, during MEDmeetsTECH, we revealed some secrets about the UES Ultra Echo Scan and Ultra Pregna Scan (LPTW) technologies we…
We had the extraordinary pleasure of being an active participant in the prestigious Gynecology and Obstetrics 360 Conference. Our appearance…